HMGB1 and HMGB2 proteins up-regulate cellular expression of human topoisomerase II
Open Access
- 17 February 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 37 (7) , 2070-2086
- https://doi.org/10.1093/nar/gkp067
Abstract
Topoisomerase IIα (topo IIα) is a nuclear enzyme involved in several critical processes, including chromosome replication, segregation and recombination. Previously we have shown that chromosomal protein HMGB1 interacts with topo IIα, and stimulates its catalytic activity. Here we show the effect of HMGB1 on the activity of the human topo IIα gene promoter in different cell lines. We demonstrate that HMGB1, but not a mutant of HMGB1 incapable of DNA bending, up-regulates the activity of the topo IIα promoter in human cells that lack functional retinoblastoma protein pRb. Transient over-expression of pRb in pRb-negative Saos-2 cells inhibits the ability of HMGB1 to activate the topo IIα promoter. The involvement of HMGB1 and its close relative, HMGB2, in modulation of activity of the topo IIα gene is further supported by knock-down of HMGB1/2, as evidenced by significantly decreased levels of topo IIα mRNA and protein. Our experiments suggest a mechanism of up-regulation of cellular expression of topo IIα by HMGB1/2 in pRb-negative cells by modulation of binding of transcription factor NF-Y to the topo IIα promoter, and the results are discussed in the framework of previously observed pRb-inactivation, and increased levels of HMGB1/2 and topo IIα in tumors.Keywords
This publication has 75 references indexed in Scilit:
- Mechanism of high-mobility group protein B enhancement of progesterone receptor sequence-specific DNA bindingNucleic Acids Research, 2008
- Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancerBreast Cancer Research and Treatment, 2008
- Upregulation of topoisomerase IIα expression in advanced gallbladder carcinoma: a potential chemotherapeutic targetZeitschrift für Krebsforschung und Klinische Onkologie, 2008
- HMGB1 interacts with human topoisomerase II and stimulates its catalytic activityNucleic Acids Research, 2007
- Topoisomerase II alpha amplification may predict benefit from adjuvant anthracyclines in HER2 positive early breast cancerBreast Cancer Research and Treatment, 2007
- The retinoblastoma gene and its product are targeted by ICBP90: a key mechanism in the G1/S transition during the cell cycleOncogene, 2005
- Chromatin Immunoprecipitation (ChIP) on Chip Experiments Uncover a Widespread Distribution of NF-Y Binding CCAAT Sites Outside of Core PromotersPublished by Elsevier ,2005
- The p53 Tumor Suppressor Stimulates the Catalytic Activity of Human Topoisomerase IIα by Enhancing the Rate of ATP HydrolysisJournal of Biological Chemistry, 2000
- DNA‐binding properties of the tandem HMG boxes of high‐mobility‐group protein 1 (HMG1)European Journal of Biochemistry, 1998
- The specific interactions of HMG 1 and 2 with negatively supercoiled DNA are modulated by their acidic C-terminal domains and involve cysteine residues in their HMG 1/2 boxesBiochemistry, 1993